Literature DB >> 21972403

Effects of hydration in contrast-induced acute kidney injury after primary angioplasty: a randomized, controlled trial.

Mauro Maioli1, Anna Toso, Mario Leoncini, Carlo Micheletti, Francesco Bellandi.   

Abstract

BACKGROUND: Intravascular volume expansion represents a beneficial measure against contrast-induced acute kidney injury (CI-AKI) in patients undergoing elective angiographic procedures. However, the efficacy of this preventive strategy has not yet been established for patients with ST-elevation-myocardial infarction (STEMI), who are at higher risk of this complication after primary percutaneous coronary intervention (PCI). In this randomized study we investigated the possible beneficial role of periprocedural intravenous volume expansion and we compared the efficacy of 2 different hydration strategies in patients with STEMI undergoing primary PCI. METHODS AND
RESULTS: We randomly assigned 450 STEMI patients to receive (1) preprocedure and postprocedure hydration of sodium bicarbonate (early hydration group), (2) postprocedure hydration of isotonic saline (late hydration group), or (3) no hydration (control group). The primary end point was the development of CI-AKI, defined as an increase in serum creatinine of ≥25% or 0.5 mg/dL over the baseline value within 3 days after administration of the contrast medium. Moreover, we evaluated a possible relationship between the occurrence of CI-AKI and total hydration volume administered. There were no significant differences in baseline clinical, biochemical, and procedural characteristics in the 3 groups. Overall, CI-AKI occurred in 93 patients (20.6%): the incidence was significantly lower in the early hydration group (12%) with respect to both the late hydration group (22.7%) and the control group (27.3%) (P for trend=0.001). In hydrated patients (early and late hydration groups), lower infused volumes were associated with a significant increase in CI-AKI incidence, and the optimal cutoff point of hydration volume that best discriminates patients at higher risk was ≤960 mL.
CONCLUSIONS: Adequate intravenous volume expansion may prevent CI-AKI in patients undergoing primary PCI. A regimen of preprocedure and postprocedure hydration therapy with sodium bicarbonate appears to be more efficacious than postprocedure hydration only with isotonic saline.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21972403     DOI: 10.1161/CIRCINTERVENTIONS.111.961391

Source DB:  PubMed          Journal:  Circ Cardiovasc Interv        ISSN: 1941-7640            Impact factor:   6.546


  30 in total

1.  Interventional cardiology: Hydration reduces angiographic AKI.

Authors:  Gregory B Lim
Journal:  Nat Rev Cardiol       Date:  2011-10-25       Impact factor: 32.419

Review 2.  Does bicarbonate prevent contrast-induced nephropathy in cardiovascular patients undergoing contrast imaging?

Authors:  Dilan Dabare; Mohammed Banihani; Paul Gibbs; Perbinder Grewal
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-08-30

3.  Reducing Acute Kidney Injury Due to Contrast Material: How Nurses Can Improve Patient Safety.

Authors:  Peggy Lambert; Kristine Chaisson; Susan Horton; Carmen Petrin; Emily Marshall; Sue Bowden; Lynn Scott; Sheila Conley; Janette Stender; Gertrude Kent; Ellen Hopkins; Brian Smith; Anita Nicholson; Nancy Roy; Brenda Homsted; Cindy Downs; Cathy S Ross; Jeremiah Brown
Journal:  Crit Care Nurse       Date:  2017-02       Impact factor: 1.708

Review 4.  Comparative efficacy of pharmacological interventions for contrast-induced nephropathy prevention after coronary angiography: a network meta-analysis from randomized trials.

Authors:  Wen-Qi Ma; Yu Zhao; Ying Wang; Xi-Qiong Han; Yi Zhu; Nai-Feng Liu
Journal:  Int Urol Nephrol       Date:  2018-02-05       Impact factor: 2.370

5.  Guideline on the use of iodinated contrast media in patients with kidney disease 2018.

Authors:  Yoshitaka Isaka; Hiromitsu Hayashi; Kazutaka Aonuma; Masaru Horio; Yoshio Terada; Kent Doi; Yoshihide Fujigaki; Hideo Yasuda; Taichi Sato; Tomoyuki Fujikura; Ryohei Kuwatsuru; Hiroshi Toei; Ryusuke Murakami; Yoshihiko Saito; Atsushi Hirayama; Toyoaki Murohara; Akira Sato; Hideki Ishii; Tadateru Takayama; Makoto Watanabe; Kazuo Awai; Seitaro Oda; Takamichi Murakami; Yukinobu Yagyu; Nobuhiko Joki; Yasuhiro Komatsu; Takamasa Miyauchi; Yugo Ito; Ryo Miyazawa; Yoshihiko Kanno; Tomonari Ogawa; Hiroki Hayashi; Eri Koshi; Tomoki Kosugi; Yoshinari Yasuda
Journal:  Clin Exp Nephrol       Date:  2020-01       Impact factor: 2.801

6.  Guideline on the use of iodinated contrast media in patients with kidney disease 2018.

Authors:  Yoshitaka Isaka; Hiromitsu Hayashi; Kazutaka Aonuma; Masaru Horio; Yoshio Terada; Kent Doi; Yoshihide Fujigaki; Hideo Yasuda; Taichi Sato; Tomoyuki Fujikura; Ryohei Kuwatsuru; Hiroshi Toei; Ryusuke Murakami; Yoshihiko Saito; Atsushi Hirayama; Toyoaki Murohara; Akira Sato; Hideki Ishii; Tadateru Takayama; Makoto Watanabe; Kazuo Awai; Seitaro Oda; Takamichi Murakami; Yukinobu Yagyu; Nobuhiko Joki; Yasuhiro Komatsu; Takamasa Miyauchi; Yugo Ito; Ryo Miyazawa; Yoshihiko Kanno; Tomonari Ogawa; Hiroki Hayashi; Eri Koshi; Tomoki Kosugi; Yoshinari Yasuda
Journal:  Jpn J Radiol       Date:  2020-01       Impact factor: 2.374

Review 7.  Meta-Analysis of Individual Patient Data of Sodium Bicarbonate and Sodium Chloride for All-Cause Mortality After Coronary Angiography.

Authors:  Jeremiah R Brown; Daniel M Pearlman; Emily J Marshall; Shama S Alam; Todd A MacKenzie; Alejandro Recio-Mayoral; Vitor O Gomes; Bokyung Kim; Lisette O Jensen; Christian Mueller; Mauro Maioli; Richard J Solomon
Journal:  Am J Cardiol       Date:  2016-08-24       Impact factor: 2.778

8.  Intravascular ultrasound guidance to minimize the use of iodine contrast in percutaneous coronary intervention: the MOZART (Minimizing cOntrast utiliZation With IVUS Guidance in coRonary angioplasTy) randomized controlled trial.

Authors:  José Mariani; Cristiano Guedes; Paulo Soares; Silvio Zalc; Carlos M Campos; Augusto C Lopes; André G Spadaro; Marco A Perin; Antonio Esteves Filho; Celso K Takimura; Expedito Ribeiro; Roberto Kalil-Filho; Elazer R Edelman; Patrick W Serruys; Pedro A Lemos
Journal:  JACC Cardiovasc Interv       Date:  2014-10-15       Impact factor: 11.195

Review 9.  Prevention of contrast-induced AKI: a review of published trials and the design of the prevention of serious adverse events following angiography (PRESERVE) trial.

Authors:  Steven D Weisbord; Martin Gallagher; James Kaufman; Alan Cass; Chirag R Parikh; Glenn M Chertow; Kendrick A Shunk; Peter A McCullough; Michael J Fine; Maria K Mor; Robert A Lew; Grant D Huang; Todd A Conner; Mary T Brophy; Joanne Lee; Susan Soliva; Paul M Palevsky
Journal:  Clin J Am Soc Nephrol       Date:  2013-05-09       Impact factor: 8.237

10.  Reducing contrast-induced acute kidney injury using a regional multicenter quality improvement intervention.

Authors:  Jeremiah R Brown; Richard J Solomon; Mark J Sarnak; Peter A McCullough; Mark E Splaine; Louise Davies; Cathy S Ross; Harold L Dauerman; Janette L Stender; Sheila M Conley; John F Robb; Kristine Chaisson; Richard Boss; Peggy Lambert; David J Goldberg; Deborah Lucier; Frank A Fedele; Mirle A Kellett; Susan Horton; William J Phillips; Cynthia Downs; Alan Wiseman; Todd A MacKenzie; David J Malenka
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2014-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.